Intranasal Saline Placebo

Preclinical

SSeoul National University Childrens Hospital

Intranasal Saline Placebo is one of 3 therapeutic programs targeting Procedural Sedation. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[2][1]

Indication

Procedural SedationNot yet recruiting

Procedural SedationPreclinical

Not yet recruiting

Competition

Competitive Landscape

3 competitors in Procedural Sedation

#DrugCompanyPhaseTrials

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 2

Aquachloral

SSeoul National University Hospital

Preclinical

1 3

Intranasal Saline Placebo

SSeoul National University Childrens Hospital

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2028

PreclinicalNot yet recruiting

Procedural Sedation

NCT07768566

Clinical

Trials by Indication[1]

Procedural Sedation1 trial

Procedural Sedation With Intranasal Dexmedetomidine Versus Oral Chloral Hydrate for Painful Orthopedic Manipulation: A Prospective Randomized Controlled Study

Not yet recruiting·SSeoul National University Childrens Hospital·Preclinical·NCT07768566·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Intranasal Saline Placebo. U.S. National Library of Medicine, National Institutes of Health.
[2]
Open Targets Platform — Drug–disease associations for Intranasal Saline Placebo. EMBL-EBI & Wellcome Sanger Institute.
[3]
SEC EDGAR — Seoul National University Childrens Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Highest Phase: Preclinical[1]
Company: SSeoul National University Childrens Hospital

Intranasal Saline Placebo

Status by Indication[2][1]

Competitive Landscape

Expected Milestones

Q4 2028

Trials by Indication[1]

Procedural Sedation1 trial

References

Drug Info

Quick Facts

Related News